This ranking for 2013 of the top 20 pharmaceutical products sold in the Russian hospital market during the year, organized by sales value, demoninates each drug according to its international nonproprietary name (INN), as denominated by the World Health Organization (WHO).
Source: Pharmon / Aston Consulting
A map showing 18 of the active clinical trials sites in Malaysia in 2017. The sites are spread across the entire…
The Egyptian pharma market grew at a compound annual growth rate (CAGR) of 17 percent between 2011 and 2017 to…
125 medicines for rare diseases were approved by the EMA between 2004 and 2014, of which 71 were granted orphan…
An outline of the geographical distribution of clinical trial sites in South Korea. 184 medical institutions were…
80 orphan drugs (those drugs intended to treat diseases so rare that sponsors are reluctant to develop them under…
There is much debate surrounding the potential impact on the UK’s life sciences industry of the…
When the Russian Federation emerged from the former USSR in 1991 all the structures of the past social net…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has…
